https://www.healio.com/news/endocrinology/20230103/fda-approves-onceweekly-semaglutide-for-adolescents-with-obesity
0
0
FDA approves once-weekly semaglutide for adolescents with obesity - Healio
1/3/23 at 11:40am
Organization
Healio
Authors
Details
55 words
Summarize
Health Obesity FDA BMI
The FDA approved once-weekly semaglutide for the treatment of obesity among adolescents aged 12 to 17 years with an initial BMI in the 95th percentile for age and sex, according to a press release. The FDA’s new indication for semaglutide (Wegovy, Novo…
Create an account or login to join the discussion